FindTrial
Sign In

To find out how many people have less platelet count during 9th month of pregnancy

Prevalence of Thrombocytopenia in pregnant women from 34-38 weeks- descriptive observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/02/049700
Enrollment
155
Registered
2023-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O991- Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: antinatal women more than 33 weeks 6 days and less than 37 weeks 6 days

Exclusion criteria

Exclusion criteria: antinatal women less than 34weeks and more than 38 weeks known case of hematological disorders patient not willing to participate

Design outcomes

Primary

MeasureTime frame
39 weeksTimepoint: 38-39 weeks—

Secondary

MeasureTime frame
other immune realted thrombocytic conditionsTimepoint: 1 year—

Countries

India

Contacts

Public ContactShivapriya K S

JAWAHARLAL NEHRU MEDICAL COLLEGE,KLE ACADEMY

shivapriyaselva@gmail.com8310470645

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026